Merck Germany Regains Exclusive Global Rights To Cancer Drug From Pfizer
Germany’s Merck KGaA (OTC: MKGAF) (OTC: MKKGY) has regained exclusive worldwide rights to develop, manufacture, and commercialize its checkpoint blocker Bavencio (avelumab) from Pfizer Inc (NYSE:PFE).…